Omico’s development and growth in precision oncology, recently boosted by significant funding in the 2026-27 Budget, is also producing a substantial library of patient-level data that demonstrates that genomic profiling of tumours changes lives and could reshape how Australia funds and delivers cancer care. …
Omico is evolving tumour genomics into hard evidence for precision oncology
June 8, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
New report highlights the potential health-system benefits of pharmacist prescribing
June 9, 2026 - - Latest News -
It was an unintentionally revealing discussion about the history and reality of agreements
June 9, 2026 - - Latest News -
R&D tax shake up risks sending Australia’s biotech talent and jobs overseas
June 9, 2026 - - Latest News -
Rare Cancers Australia co-founder Kate Vines recognised in King's Birthday Honours
June 8, 2026 - - Latest News -
Omico is evolving tumour genomics into hard evidence for precision oncology
June 8, 2026 - - Latest News -
The 'Dispatched' Podcast - Special episode
June 5, 2026 - - Podcast -
Opthea returns to ASX and works to restart eye therapy candidate
June 5, 2026 - - Latest News